Clinical Trial Update: A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase I study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of SXRN Injection in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Solid Tumors

Drugs mentioned

• SXRN Injection

Snippet

Sponsor: Jiangsu Nutai Biologics Co., Ltd | Conditions: Cachexia-Anorexia Syndrome, Solid Tumor Malignancies | Phase 1 | Status: RECRUITING